Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A known ✓ | P28223 | 7/20 | 0.36 |
| ▸ | HTR2C known ✓ | P28335 | 6/20 | 0.36 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.36 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.36 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.36 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.36 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL8874318 | 1.00 | CYP3A4 (0.41) | CYP3A4CYP1A2HSD17B10KDM4EALOX15 | |
| SCHEMBL9239604 | 0.88 | HTR2A (0.40) | KDM4EHTR2AHTR2CLMNACHRM2 | |
| Fumaric Acid SCHEMBL8874351 | 0.88 | MITF (0.40) | CYP3A4HSD17B10TSHRHTR2AHTR2C | |
| Fumaric Acid SCHEMBL8874359 | 0.88 | MITF (0.40) | CYP3A4HSD17B10TSHRHTR2AHTR2C | |
| Fumaric Acid SCHEMBL8875813 | 0.83 | MEN1 (0.38) | HSD17B10KDM4ETSHRMAPK1LMNA | |
| Fumaric Acid SCHEMBL8875809 | 0.83 | MEN1 (0.38) | HSD17B10KDM4ETSHRMAPK1LMNA | |
| Fumaric Acid SCHEMBL8873545 | 0.80 | HTR2C (0.57) | CYP3A4CYP1A2KDM4EHTR2AHTR2C | |
| Fumaric Acid SCHEMBL8873552 | 0.80 | HTR2C (0.57) | CYP3A4CYP1A2KDM4EHTR2AHTR2C | |
| Fumaric Acid SCHEMBL8873381 | 0.76 | BCHE (0.34) | CYP3A4HSD17B10KDM4ETSHRHTR2A | |
| Fumaric Acid SCHEMBL8873388 | 0.76 | BCHE (0.34) | CYP3A4HSD17B10KDM4ETSHRHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5646173-A | ANTISEROTONINE AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS; ANTIDEPRESSANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-07-08 | — | — | US | disclosed |